About
Curative cell-based immunotherapies
Areas of Focus
Categories
Stem Cell & Cellular TherapyBiotech
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
776
By Phase
PHASE3: 1PHASE1/PHASE2: 2PHASE1: 2
By Status
TERMINATED: 3NOT_YET_RECRUITING: 1WITHDRAWN: 1RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT07188558Lead Sponsor
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
PHASE3Not yet recruiting
400 participants
Started: Jan 31, 2026 · Completed: Jan 31, 2032
NCT06153095Lead Sponsor
A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
PHASE1/PHASE2Withdrawn
Started: Feb 15, 2024 · Completed: Jan 9, 2025
NCT05891197Lead Sponsor
A Biomarker Screening Protocol for Participants With Solid Tumors
N/ATerminated
10 participants
Started: May 19, 2023 · Completed: Feb 5, 2025
NCT05826535Lead Sponsor
Study of LYL314 in Aggressive Large B-Cell Lymphoma
PHASE1/PHASE2Recruiting
270 participants
Started: May 9, 2023 · Completed: Jun 30, 2031
NCT05573035Lead Sponsor
A Study to Investigate LYL845 in Adults With Solid Tumors
PHASE1Terminated
39 participants
Started: Dec 19, 2022 · Completed: Jan 9, 2025
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...